Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity ...
As NASA fought to catch up to the Soviet Union in the space race, they selected a Navy veteran as the first astronaut. But ...
Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness ...
Dexcom () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smarter ...
2d
DXCM Q1 Deep Dive: U.S. Growth Moderates as Product Momentum and Coverage Expansion Drive Strategy
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results topping the market’s revenue expectations, with sales ...
Zacks Investment Research on MSN
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
DexCom, Inc. DXCM reported first-quarter 2026 adjusted earnings per share (EPS) of 56 cents, which beat the Zacks Consensus ...
Xiaomi is rolling out Android 17 beta for several smartphones. Check if yours is on the list and the steps to install the ...
Q1 2026 earnings call: 15% revenue growth, Prime coverage expansion, G7 15 Day rollout, and raised margin outlook.
DexCom (NASDAQ: DXCM) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the ...
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped by strong demand for its ...
A new study suggests that the effectiveness of widely used GLP-1 weight-loss drugs may depend strongly on consistent use.
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results